Letters Adverse drug reactions

Reporting guidelines for pharmacoepidemiological studies are urgently needed

BMJ 2014; 349 doi: http://dx.doi.org/10.1136/bmj.g5511 (Published 17 September 2014) Cite this as: BMJ 2014;349:g5511
  1. Mahyar Etminan, drug safety researcher1
  1. 1Room A4-195, 950 West 28th Avenue, Vancouver, BC, Canada
  1. metminan{at}popi.ubc.ca

Tan and colleagues discuss factors that contribute to inconsistent information on drug adverse reactions but do not mention the lack of reporting guidelines for pharmacoepidemiological studies.1

Most medical journals require authors to complete checklists that are shortened versions of reporting guidelines, such as CONSORT (randomised trials), PRIMSA (systematic reviews), and …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe